Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: Molecular-cellular and functional assessment

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Fu, Morgan ^a   Sun, Cheuk Kwan ^a,b   Lin, Yu Chun ^a   Wang, Ching Jen ^a   Wu, Chiung Jen ^a   Ko, Sheung Fat ^a   Chua, Sarah ^a   Sheu, Jiunn Jye ^a   Chiang, Chiang Hua ^c   Shao, Pei Lin ^d   Leu, Steve ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD31 ANTIGEN; CD40 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYTOCHROME C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; MESSENGER RNA; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BAX; PROTEIN BCL 2; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOCARDIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL NUCLEUS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPHY; EXTRACORPOREAL LITHOTRIPSY; GENE EXPRESSION; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE REMODELING; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; ANIMAL; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MINIPIG; RADIATION; RADIATION EXPOSURE; SWINE;

AMEROIDEA; SUIDAE;

ANIMALS; ECHOCARDIOGRAPHY; HIGH-ENERGY SHOCK WAVES; MALE; SWINE; SWINE, MINIATURE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 80052507042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024342     Document Type: Article

References (35)

1. van der Wal AC, Becker AE, van der Loos CM, Das PK, (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44.
2. Epstein FH, Ross R, (1999) Atherosclerosis, Äî An Inflammatory Disease. New England Journal of Medicine 340: 115-126.
3. Corti R, Fuster V, Badimon JJ, (2003) Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 41: 7S-14S.
4. Desai NR, Bhatt DL, (2010) The state of periprocedural antiplatelet therapy after recent trials. JACC Cardiovasc Interv 3: 571-583.
5. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, et al. (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356: 1503-1516.
6. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, et al. (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344: 563-570.
7. (1982) Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group. Lancet 2: 1173-1180.
8. Yip HK, Wu CJ, Chang HW, Fang CY, Yang CH, et al. (2003) Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol 92: 1331-1335.
9. Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, et al. (2007) Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial. J Am Coll Cardiol 49: 1676-1683.
10. Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, et al. (2007) 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation 116: 2762-2772.
11. Manske CL, Wang Y, Rector T, Wilson RF, White CW, (1992) Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340: 998-1002.
12. Detre KM, Guo P, Holubkov R, Califf RM, Sopko G, et al. (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation 99: 633-640.
13. Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ Jr, et al. (2000) Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86: 485-489.
14. Ogden JA, Toth-Kischkat A, Schultheiss R, (2001) Principles of shock wave therapy. Clin Orthop Relat Res pp. 8-17.
15. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, et al. (2004) Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 110: 3055-3061.
16. Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, et al. (2008) Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med 214: 151-158.
17. Zimpfer D, Aharinejad S, Holfeld J, Thomas A, Dumfarth J, et al. (2009) Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thorac Cardiovasc Surg 137: 963-970.
18. Ma HZ, Zeng BF, Li XL, (2007) Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves. Calcif Tissue Int 81: 124-131.
19. Wang CJ, Wang FS, Yang KD, Weng LH, Hsu CC, et al. (2003) Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res 21: 984-989.
20. Yip HK, Chang LT, Sun CK, Youssef AA, Sheu JJ, et al. (2008) Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J 72: 150-156.
21. Wang CJ, Huang HY, Pai CH, (2002) Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg 41: 16-22.
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A, (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
23. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, et al. (2009) Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 37: 1197-1205.
24. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, et al. (2006) Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 114: 2823-2830.
25. Larking AM, Duport S, Clinton M, Hardy M, Andrews K, (2010) Randomized control of extracorporeal shock wave therapy versus placebo for chronic decubitus ulceration. Clin Rehabil 24: 222-229.
26. Saggini R, Figus A, Troccola A, Cocco V, Saggini A, et al. (2008) Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol 34: 1261-1271.
27. Ito Y, Ito K, Shiroto T, Tsuburaya R, Yi GJ, et al. (2010) Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo. Coron Artery Dis 21: 304-311.
28. Wang Y, Guo T, Cai HY, Ma TK, Tao SM, et al. (2010) Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease. Clin Cardiol 33: 693-699.
29. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, et al. (2010) Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J 74: 589-591.
30. Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, et al. (2008) Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol 28: 954-960.
31. Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, et al. (2008) Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J 72: 1336-1345.
32. Garrido AM, Griendling KK, (2009) NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158.
33. Chua S, Sun CK, Yen CH, Ko SF, Chang LT, et al. (2009) Autologous transplantation of shock wave-treated bone marrow-derived mononuclear cells enhances vascularization and connexin43 expression in rat dilated cardiomyopathy. Acta Cardiol Sin 25: 64-75.
34. Jalife J, Morley GE, Vaidya D, (1999) Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol 10: 1649-1663.
35. Vozzi C, Dupont E, Coppen SR, Yeh HI, Severs NJ, (1999) Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 31: 991-1003.